{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:29:54Z","timestamp":1793406594974,"version":"4.5.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,3]]},"abstract":"<jats:p>\n                    Direct oral anticoagulants (DOACs) have transformed the management of thromboembolic disorders owing to their favorable pharmacologic profiles and ease of use. Despite their increasing use, data on the knowledge of DOACs among community pharmacists are limited, particularly in Saudi Arabia, where pharmacists assume substantial clinical responsibilities. Therefore, this study aimed to assess community pharmacists\u2019 knowledge of DOAC therapy in Saudi Arabia, focusing on 3 domains: safety, efficacy, and patient counseling. A cross-sectional survey of 390 community pharmacists across Saudi Arabia was conducted between October and December 2024 using a validated 19-item questionnaire. The percentage awareness score was calculated across 3 domains. The data analysis involved using\n                    <jats:italic toggle=\"yes\">t<\/jats:italic>\n                    -tests and analysis of variance to evaluate the associations between demographic\/professional variables and knowledge levels. The mean percentage awareness score was 53.65%, indicating moderate knowledge. Pharmacists showed better understanding of efficacy (56.10%) than of safety (52.82%), or counseling (52.74%). Male pharmacists and those who participated in anticoagulation-related workshops had significantly higher scores than did females and nonparticipants in workshops (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.002 and\u2005&lt;\u2005.005, respectively). Education level, experience, and DOAC dispensing frequency were not significantly associated with knowledge. Key gaps included confusion regarding international normalized ratio monitoring, DOAC contraindications, and reversal agents. Community pharmacists in Saudi Arabia possessed moderate knowledge of DOACs; however, notable deficiencies persisted, particularly in the safety and counseling domains. Targeted educational interventions, including case-based and workshop-style learning, are recommended to enhance clinical competency and ensure safe anticoagulation practices in outpatient settings.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044977","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:07:44Z","timestamp":1759781264000},"page":"e44977","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Assessing the knowledge and awareness of community pharmacists toward direct oral anticoagulant therapy in Saudi Arabia: A cross-sectional study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0505-1360","authenticated-orcid":false,"given":"Ahmed","family":"Basilim","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260526","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11239-013-0929-5","article-title":"Pharmacology of the new target-specific oral anticoagulants.","volume":"36","author":"Cabral","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"R2-20260526","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00228-013-1510-z","article-title":"Novel oral anticoagulants: clinical pharmacology, indications and practical considerations.","volume":"69","author":"Harder","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"R3-20260526","doi-asserted-by":"crossref","first-page":"e13974","DOI":"10.7717\/peerj.13974","article-title":"A retrospective study of real-world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia.","volume":"10","author":"Alosaimi","year":"2022","journal-title":"PeerJ"},{"key":"R4-20260526","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11739-013-0963-5","article-title":"Perioperative management of patients who are receiving a novel oral anticoagulant.","volume":"8","author":"Liew","year":"2013","journal-title":"Intern Emerg Med"},{"key":"R5-20260526","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2147\/TCRM.S84210","article-title":"New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events.","volume":"11","author":"Mekaj","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"R6-20260526","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/1076029615601492","article-title":"Direct oral anticoagulants for the management of thromboembolic disorders: the importance of adherence and persistence in achieving beneficial outcomes.","volume":"22","author":"Amin","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"key":"R7-20260526","doi-asserted-by":"crossref","first-page":"e0217302","DOI":"10.1371\/journal.pone.0217302","article-title":"The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study.","volume":"14","author":"Gulpen","year":"2019","journal-title":"PLoS One"},{"key":"R8-20260526","first-page":"e22","article-title":"Effect of medication dosing frequency on adherence in chronic diseases.","volume":"15","author":"Saini","year":"2009","journal-title":"Am J Manag Care"},{"key":"R9-20260526","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report.","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"R10-20260526","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"R11-20260526","doi-asserted-by":"crossref","first-page":"1423336","DOI":"10.3389\/fcvm.2024.1423336","article-title":"Association between changes in renal function and clinical outcomes in anticoagulated atrial fibrillation patients with marginal renal function. A nationwide observational cohort study.","volume":"11","author":"Lee","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R12-20260526","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11239-020-02042-6","article-title":"Management of venous thromboembolism in patients experiencing direct oral anticoagulant treatment failure: a single-center review of practice and outcomes.","volume":"49","author":"McIlroy","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R13-20260526","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.3390\/jcm12185955","article-title":"Management of patients treated with direct oral anticoagulants in clinical practice and challenging scenarios.","volume":"12","author":"Luc\u00e0","year":"2023","journal-title":"J Clin Med"},{"key":"R14-20260526","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2147\/TCRM.S88911","article-title":"Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence.","volume":"13","author":"Willett","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"R15-20260526","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/jac5.1288","article-title":"Role of pharmacists during the COVID-19 pandemic in China\u2013Shanghai experiences.","volume":"3","author":"Liao","year":"2020","journal-title":"J Am Coll Clin Pharm"},{"key":"R16-20260526","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.5888\/pcd17.200317","article-title":"Community pharmacists\u2019 contributions to disease management during the COVID-19 pandemic.","volume":"17","author":"Strand","year":"2020","journal-title":"Prev Chronic Dis"},{"key":"R17-20260526","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2147\/RMHP.S248222","article-title":"Anticoagulation control of warfarin in pharmacist-led clinics versus physician-led clinics: a prospective observational study.","volume":"13","author":"Alghadeeer","year":"2020","journal-title":"Risk Manag Healthc Policy"},{"key":"R18-20260526","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jcpt.12400","article-title":"The first pharmacist-managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient-oriented outcomes.","volume":"41","author":"Elewa","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"R19-20260526","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s11096-017-0551-2","article-title":"Pharmacists\u2019 confidence when providing pharmaceutical care on anticoagulants, a multinational survey.","volume":"39","author":"Papastergiou","year":"2017","journal-title":"Int J Clin Pharm"},{"key":"R20-20260526","doi-asserted-by":"crossref","first-page":"21897","DOI":"10.1038\/s41598-021-01394-0","article-title":"Pharmacists\u2019 interventions improve health-related quality of life of rural older person on warfarin: a randomized controlled trial.","volume":"11","author":"Falami\u0107","year":"2021","journal-title":"Sci Rep"},{"key":"R21-20260526","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2146\/ajhp151026","article-title":"Evaluation of a pharmacist-led outpatient direct oral anticoagulant service.","volume":"74","author":"Ashjian","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"R22-20260526","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13584-019-0285-9","article-title":"Clinical pharmacist led Hospital-wide direct oral anticoagulant stewardship program.","volume":"8","author":"Perlman","year":"2019","journal-title":"Isr J Health Policy Res"},{"key":"R23-20260526","first-page":"134","article-title":"An evaluation of oral anticoagulant safety indicators by England\u2019s community pharmacies.","volume":"12","author":"Parekh","year":"2024","journal-title":"Pharmacy (Basel)"},{"key":"R24-20260526","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.japh.2021.10.009","article-title":"Pharmacist monitoring of direct oral anticoagulants for American Indians and Alaska Natives in the outpatient setting.","volume":"62","author":"Navin","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"key":"R25-20260526","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.2015.2761","article-title":"Site-level variation in and practices associated with dabigatran adherence.","volume":"313","author":"Shore","year":"2015","journal-title":"JAMA"},{"key":"R26-20260526","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/jac5.1239","article-title":"Clinical pharmacy practice in Saudi Arabia: historical evolution and future perspective.","volume":"3","author":"Badreldin","year":"2020","journal-title":"J Am Coll Clin Pharm"},{"key":"R27-20260526","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jsps.2023.04.014","article-title":"Community pharmacist\u2019s preparedness to provide patient-centred care in Saudi Arabia.","volume":"31","author":"Rasheed","year":"2023","journal-title":"Saudi Pharm J"},{"key":"R28-20260526","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3390\/healthcare11162299","article-title":"Evaluation of outreach of community pharmacists in public health services in al-Jouf region of Saudi Arabia: findings and implications.","volume":"11","author":"Alzarea","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"R29-20260526","first-page":"2741","article-title":"Assessment of knowledge and counseling practice of warfarin among pharmacists in UAE: a cross-sectional study.","volume":"20","author":"Alkherat","year":"2022","journal-title":"Pharm Pract"},{"key":"R30-20260526","doi-asserted-by":"crossref","first-page":"1076029620933946","DOI":"10.1177\/1076029620933946","article-title":"Assessing pharmacists knowledge and attitude toward the direct oral anticoagulants in Qatar.","volume":"26","author":"El-Bardissy","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"R31-20260526","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/14779072.2021.1878878","article-title":"Use of NOACs in high-risk patients with atrial fibrillation in Saudi Arabia: perspectives on improving patient care.","volume":"19","author":"AlShoaibi","year":"2021","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R32-20260526","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/jpbs.JPBS_233_19","article-title":"Pharmacists\u2019 warfarin therapy knowledge and counseling practices in the Eastern Province, Saudi Arabia: a cross-sectional study.","volume":"12","author":"Mohamed","year":"2020","journal-title":"J Pharm Bioallied Sci"},{"key":"R33-20260526","first-page":"1215","article-title":"Community pharmacists\u2019 knowledge of direct oral anticoagulants and warfarin in the North of Jordan: a cross sectional study.","volume":"26","author":"Tahaineh","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R34-20260526","doi-asserted-by":"crossref","first-page":"227","DOI":"10.24911\/IJMDC.51-1700861186","article-title":"Public knowledge, attitude, and practice towards Helicobacter pylori infection in Saudi Arabia.","volume":"8","author":"Alkhawajah","year":"2024","journal-title":"IJMDC"},{"key":"R35-20260526","first-page":"e82913","article-title":"Knowledge and awareness of volume assessment among emergency and intensive care physicians in Saudi Arabia.","volume":"17","author":"Bafarag","year":"2025","journal-title":"Cureus"},{"key":"R36-20260526","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.3390\/ijerph18168545","article-title":"Knowledge, attitude, practices and viewpoints of undergraduate university students towards self-medication: an institution-based study in Riyadh.","volume":"18","author":"Mannasaheb","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"R37-20260526","doi-asserted-by":"crossref","first-page":"321","DOI":"10.37268\/mjphm\/vol.21\/no.2\/art.1029","article-title":"Determining factors associated with the knowledge, attitude and practice of COVID-19 pandemic among medical students in Malaysia.","volume":"21","author":"Azzeri","year":"2021","journal-title":"Malays J Public Health Med"},{"key":"R39-20260526","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.2147\/RMHP.S443325","article-title":"Trends, capacity growth, and current state of community pharmacies in Saudi Arabia: findings and implications of a 16-year retrospective study.","volume":"16","author":"Alrasheedy","year":"2023","journal-title":"Risk Manag Healthc Policy"},{"key":"R40-20260526","first-page":"e1:1","article-title":"Assessment of community pharmacists\u2019 knowledge about utilization, safety, and interactions of commonly prescribed anticoagulants: a report from North West of Iran: community pharmacists\u2019 knowledge about anticoagulants.","volume":"6","author":"Ali","year":"2023","journal-title":"Int Pharm Acta"},{"key":"R41-20260526","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jsps.2012.05.007","article-title":"Patients\u2019 perception, views and satisfaction with pharmacists\u2019 role as health care provider in community pharmacy setting at Riyadh, Saudi Arabia.","volume":"20","author":"Al-Arifi","year":"2012","journal-title":"Saudi Pharm J"},{"key":"R42-20260526","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.2147\/IDR.S324865","article-title":"Impact of educational intervention to promote Jordanian community pharmacists\u2019 knowledge and perception towards antimicrobial stewardship: pre-post interventional study.","volume":"14","author":"Saleh","year":"2021","journal-title":"Infect Drug Resist"},{"key":"R43-20260526","doi-asserted-by":"crossref","first-page":"e034674","DOI":"10.1136\/bmjopen-2019-034674","article-title":"Improving community pharmacists\u2019 clinical knowledge to detect and resolve drug-related problems in Croatia: a before\/after survey study investigating the efficacy of an educational.","volume":"10","author":"Zekan","year":"2020","journal-title":"BMJ Open"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:25:49Z","timestamp":1779805549000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":42,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044977","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"2025-07-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}